Specialty Networks Partners With Datavant to Add Real-World Data

April 25, 2022
Provider of specialty care performance and population health analytics adds data sources such as claims, labs, imaging, mortality events, and social determinants of health to its registry

Specialty Networks, a provider of urology, gastroenterology, and rheumatology care performance and population health analytics, is partnering with Datavant to offer its customers real-world data to support their clinical networks and life sciences research.

Specialty Networks serves more than 7,000 community urology providers which represents 80 percent of all independent U.S. urology physicians as well as a growing network of gastroenterology and rheumatology physician practices. Its solutions include population health management, patient engagement, clinical research, and workflow automation technologies.  

Datavant says it offers the ability to access, exchange, and connect data among the thousands of organizations in its ecosystem for use cases ranging from better clinical care and value-based payments to health analytics and medical research.

Leveraging Datavant’s ecosystem of more than 500 real-world data partners, Specialty Networks said it would link other data sources such as claims, labs, imaging, mortality events, and social determinants of health to create a complete longitudinal patient journey. Stakeholders will be able to use this de-identified data to conduct a spectrum of outcomes research across clinical development, health economics, outcomes research, medical affairs, and commercial functions to understand the patient populations and medical conditions diagnosed and treated in the community physician practice setting.

“Entering into a like-minded partnership with Datavant to create an enriched patient journey enables us to help our provider networks improve care and simultaneously create a privacy-compliant data asset that can advance research into diseases like prostate, bladder, and kidney cancers, Peyronie’s disease, overactive bladder, benign prostatic hyperplasia, inflammatory bowel disease, rheumatoid, psoriatic, and osteoarthritis, and other urological, gastroenterological, and rheumatological diseases,” said Shailendra Sharma, president of Specialty Networks, in a statement. “SoNaR — Specialty Networks Registry — represents the family of highly curated specialty registries in urology, gastroenterology, and rheumatology for various tumors and disease states.”

“Every therapeutic area is witnessing an explosion of best-in-class data and analytics companies emerging that help to make research and treatment more data-driven, creating the hope for major benefits for patients,” added Travis May, founder and president of Datavant, in a statement. “Specialty Networks is establishing a gold standard in urology for real-world evidence research with its SoNaR registry and technology stack that integrates a large proportion of independent community physician practices across the country. We're excited to work with them to connect their data to the rest of the health data ecosystem and help form a deeper understanding of diseases, diagnostics, and interventions.”

Sponsored Recommendations

How to Build Trust in AI: The Data Leaders’ Playbook

This eBook strives to provide data leaders like you with a comprehensive understanding of the urgent need to deliver high-quality data to your business. It also reviews key strategies...

Quantifying the Value of a 360-Degree view of Healthcare Consumers

To create consistency in how consumers are viewed and treated no matter where they transact, healthcare organizations must have a 360° view based on a trusted consumer profile...

Elevating Clinical Performance and Financial Outcomes with Virtual Care Management

Transform healthcare delivery with Virtual Care Management (VCM) solutions, enabling proactive, continuous patient engagement to close care gaps, improve outcomes, and boost operational...

Examining AI Adoption + ROI in Healthcare Payments

Maximize healthcare payments with AI - today + tomorrow